Khosla Ventures
Listed as “Vivodyne”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Vivodyne develops data and machine learning methods for human tissue research.
The company generates human tissue data to train foundation models and develops methods for interpreting their outputs. Its autonomous labs test human tissues grown outside the body.
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Vivodyne”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.